PROCEPT BioRobotics (PRCT) awards RSUs and stock options to CFO Kevin Waters
Rhea-AI Filing Summary
PROCEPT BioRobotics Corp reports that EVP and CFO Kevin Waters received equity awards on August 13, 2026. He was granted 29,527 RSUs, each representing a contingent right to one share of common stock, bringing his directly held common shares to 180,728. He also received a stock option for 40,851 shares of common stock at an exercise price of $21.95 per share, expiring on August 12, 2036, with 40,851 option shares outstanding after the grant.
The RSUs vest with one-quarter on August 13, 2027 and the remainder in equal quarterly installments over 36 months, subject to continued service. The option vests in 1/48th monthly installments starting August 13, 2026 over four years, also subject to continued employment or service. Both awards are intended to represent 50% of the value of Waters’ expected 2027 grant, in lieu of that portion of the 2027 award.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 29,527 shares
Net Buy
2 txns
Insider
Waters Kevin
Role
EVP, CFO
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) F2 | 40,851 | $0.00 | $0.00 |
| Grant/Award | Common Stock F1 | 29,527 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (Right to Buy) — 40,851 shares (Direct);
Common Stock — 180,728 shares (Direct)
Footnotes (2)
- F1. These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock. One-quarter of the RSUs shall vest on August 13, 2027, with one-sixteenth of the remaining RSUs vesting quarterly over 36 months, subject to the Reporting Person continuing as a service provider through such date. The grant is intended to be 50% of the value of the Reporting Person's expected 2027 grant, and made in lieu of such portion of the expected 2027 grant.
- F2. 1/48th of the shares subject to the Stock Option shall vest monthly from the vesting commencement date of August 13, 2026, over a four year period, subject continued employment or service by the Reporting Person to the Issuer through the applicable vesting date. The grant is intended to be 50% of the value of the Reporting Person's expected 2027 grant, and made in lieu of such portion of the expected 2027 grant.
Key Figures
RSUs granted: 29,527 RSUs
Options granted: 40,851 shares
Option exercise price: $21.95 per share
+5 more
8 metrics
RSUs granted
29,527 RSUs
Restricted stock units granted to Kevin Waters on August 13, 2026
Options granted
40,851 shares
Stock option covering common stock granted on August 13, 2026
Option exercise price
$21.95 per share
Conversion or exercise price for the new stock option
Common shares held
180,728 shares
Total directly held common stock after RSU grant
Option expiration
August 12, 2036
Expiration date of the 40,851-share stock option
RSU vesting start
August 13, 2027
Date when one-quarter of RSUs vest, remaining vest quarterly over 36 months
Monthly option vesting fraction
1/48th per month
Portion of option shares vesting monthly from August 13, 2026 over four years
Portion of expected 2027 grant
50% of value
Both RSUs and options made in lieu of half of expected 2027 grant value
Key Terms
restricted stock units (RSUs), contingent right to receive one share of Common Stock, vesting commencement date, Stock Option (Right to Buy)
4 terms
restricted stock units (RSUs) financial
"These securities are restricted stock units (RSUs). Each RSU represents"
Restricted stock units (RSUs) are a type of company promise to give employees shares of stock in the future, usually after certain conditions like working for a set time. They are like a gift promised today that you receive later, which can become valuable if the company's stock price goes up. RSUs matter because they are a way companies reward employees and can be a significant part of compensation.
vesting commencement date financial
"1/48th of the shares subject to the Stock Option shall vest monthly from the vesting commencement date"
The vesting commencement date is the starting point when an employee begins earning ownership rights to their promised benefits, such as stock options or retirement contributions. Think of it like the day a savings account is opened—only after this date do the benefits start to grow and become fully available over time. It matters to investors because it marks when the clock begins ticking toward full ownership, affecting the timing and value of these benefits.
Stock Option (Right to Buy) financial
"security_title: Stock Option (Right to Buy)"
FAQ
What equity awards did PROCEPT BioRobotics (PRCT) grant to CFO Kevin Waters?
On August 13, 2026, Kevin Waters received 29,527 RSUs and a stock option for 40,851 shares of common stock at an exercise price of $21.95, both as part of his long-term equity compensation.
How do the new RSUs for PROCEPT BioRobotics (PRCT) CFO vest?
The 29,527 RSUs vest with one-quarter on August 13, 2027, and the remaining three-quarters vest in equal quarterly installments over 36 months, contingent on Kevin Waters continuing as a service provider.
What is the vesting schedule of the new stock option granted by PROCEPT BioRobotics (PRCT)?
The stock option for 40,851 shares vests at 1/48th of the shares monthly starting from the vesting commencement date of August 13, 2026, over four years, subject to Waters’ continued employment or service.
What is the expiration date of the new stock option granted by PROCEPT BioRobotics (PRCT)?
The stock option granted to Kevin Waters, covering 40,851 shares of common stock at $21.95 per share, has an expiration date of August 12, 2036, assuming it remains outstanding under its terms.
AI-generated analysis. How Rhea-AI works. Not financial advice.
